Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study

Journal of Clinical Oncology

Volumn 32, Issue 12, 2014, Pages 1218-1227

  Armstrong, Gregory T ^a   Kawashima, Toana ^b   Leisenring, Wendy ^b   Stratton, Kayla ^b   Stovall, Marilyn ^c   Hudson, Melissa M ^a   Sklar, Charles A ^d   Robison, Leslie L ^a   Oeffinger, Kevin C ^d  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; BLEOMYCIN; CISPLATIN; METHOTREXATE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; AGING; APPARENT LIFE THREATENING EVENT; ARTICLE; BONE TUMOR; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVOR; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; FATALITY; FEMALE; HEALTH HAZARD; HODGKIN DISEASE; HUMAN; KIDNEY TUMOR; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; POPULATION; PRIORITY JOURNAL; SIBLING; SOFT TISSUE SARCOMA; COHORT ANALYSIS; FOLLOW UP; LONGITUDINAL STUDY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NEOPLASM; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; STATISTICS; SURVIVOR; UNITED STATES;

ADULT; AGE FACTORS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MORBIDITY; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVORS; UNITED STATES;

EID: 84903604562     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.51.1055     Document Type: Article

References (36)

1. Howlader N, Noone AM, Krapcho M, et al (eds): SEER Cancer Statistics Review, 1975-2008. Bethesda, MD, National Cancer Institute, 2012
2. Mariotto AB, Rowland JH, Yabroff KR, et al: Long-term survivors of childhood cancers in the United States. Cancer Epidemiol Biomarkers Prev 18:1033-1040, 2009
3. Hudson MM, Ness KK, Gurney JG, et al: Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 309:2371-2381, 2013
4. Oeffinger KC, Mertens AC, Sklar CA, et al: Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355:1572-1582, 2006 (Pubitemid 44547808)
5. Mertens AC, Liu Q, Neglia JP, et al: Cause-specific late mortality among 5-year survivors of childhood cancer: The Childhood Cancer Survivor Study. J Natl Cancer Inst 100:1368-1379, 2008
6. Friedman DL, Whitton J, Leisenring W, et al: Subsequent neoplasms in 5-year survivors of childhood cancer: The Childhood Cancer Survivor Study. J Natl Cancer Inst 102:1083-1095, 2010
7. Robison LL, Armstrong GT, Boice JD, et al: The Childhood Cancer Survivor Study: A National Cancer Institute-supported resource for outcome and intervention research. J Clin Oncol 27:2308-2318, 2009
8. Leisenring WM, Mertens AC, Armstrong GT, et al: Pediatric cancer survivorship research: Experience of the Childhood Cancer Survivor Study. J Clin Oncol 27:2319-2327, 2009
9. Robison LL, Mertens AC, Boice JD, et al: Study design and cohort characteristics of the Childhood Cancer Survivor Study: A multi-institutional collaborative project. Med Pediatr Oncol 38:229-239, 2002 (Pubitemid 34258414)
10. Cancer Therapy Evaluation Program: Common terminology criteria for adverse events, version 3.0. National Cancer Institute, Bethesda, MD. http://ctep.cancer.gov
11. Neglia JP, Friedman DL, Yasui Y, et al: Second malignant neoplasms in five-year survivors of childhood cancer: Childhood cancer survivor study. J Natl Cancer Inst 93:618-629, 2001 (Pubitemid 32409629)
12. Meadows AT, Friedman DL, Neglia JP, et al: Second neoplasms in survivors of childhood cancer: Findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol 27:2356-2362, 2009
13. Stovall M, Weathers R, Kasper C, et al: Dose reconstruction for therapeutic and diagnostic radiation exposures: Use in epidemiological studies. Radiat Res 166:141-157, 2006 (Pubitemid 44051207)
14. Andersen PK, Gill RD: Cox's regression model for counting processes: A large sample study. Ann Stat 10:1100-1120, 1982
15. Lin DY, Wei LJ: The robust inference for the Cox proportional hazards model. J Am Stat Assoc 84:1074-1078, 1989
16. Robins JM, Hernán MA, Brumback B: Marginal structural models and causal inference in epidemiology. Epidemiology 11:550-560, 2000 (Pubitemid 30660034)
17. Stone CJ, Koo CY: Proceedings of the Statistical Computing Section ASA. American Statistical Association, Washington, DC, 1985, pg 45
18. Gooley TA, Leisenring W, Crowley J, et al: Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med 18:695-706, 1999 (Pubitemid 29126745)
19. Heisey DM, Patterson BR: A review of methods to estimate cause-specific mortality in presence of competing risks. J Wildl Manage 70:1544-1555, 2006 (Pubitemid 46214490)
20. Geenen MM, Cardous-Ubbink MC, Kremer LC, et al: Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA 297:2705-2715, 2007 (Pubitemid 47001096)
21. Landier W, Armenian SH, Lee J, et al: Yield of screening for long-term complications using the Children's Oncology Group long-term follow-up guidelines. J Clin Oncol 30:4401-4408, 2012
22. Hewitt M, Weiner SL, Simone JV, et al (eds): Childhood Cancer Survivorship: Improving Care and Quality of Life. Washington, DC, National Academy Press, 2003
23. Armstrong GT, Liu W, Leisenring W, et al: Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Clin Oncol 29:3056-3064, 2011
24. Oeffinger KC, Ford JS, Moskowitz CS, et al: Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer. JAMA 301:404-414, 2009
25. Henderson TO, Oeffinger KC, Whitton J, et al: Secondary gastrointestinal cancer in childhood cancer survivors: A cohort study. Ann Intern Med 156: 757-766, 2012
26. Landier W, Bhatia S, Eshelman DA, et al: Development of risk-based guidelines for pediatric cancer survivors: The Children's Oncology Group long-term follow-up guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 22:4979-4990, 2004 (Pubitemid 46638624)
27. Lipshultz SE, Lipsitz SR, Sallan SE, et al: Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer. J Clin Oncol 20:4517-4522, 2002 (Pubitemid 35402954)
28. Armstrong GT, Plana JC, Zhang N, et al: Screening adult survivors of childhood cancer for cardiomyopathy: Comparison of echocardiography and cardiac magnetic resonance imaging. J Clin Oncol 30:2876-2884, 2012
29. Cardinale D, Colombo A, Lamantia G, et al: Anthracycline-induced cardiomyopathy: Clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol 55:213-220, 2010
30. Ness KK, Hudson MM, Ginsberg JP, et al: Physical performance limitations in the Childhood Cancer Survivor Study cohort. J Clin Oncol 27:2382-2389, 2009
31. Mulrooney DA, Ness KK, Neglia JP, et al: Fatigue and sleep disturbance in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS). Sleep 31:271-281, 2008 (Pubitemid 351536529)
32. Ness KK, Krull KR, Jones KE, et al: Physiologic frailty as a sign of accelerated aging among adult survivors of childhood cancer: A report from the St Jude lifetime cohort study. J Clin Oncol 31:4496-4503, 2013
33. Armstrong GT, Reddick WE, Petersen RC, et al: Evaluation of memory impairment in aging adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiotherapy. J Natl Cancer Inst 105:899-907, 2013
34. Maccormick RE: Possible acceleration of aging by adjuvant chemotherapy: A cause of early onset frailty? Med Hypotheses 67:212-215, 2006
35. Hudson MM, Neglia JP, Woods WG, et al: Lessons from the past: Opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies. Pediatr Blood Cancer 58:334-343, 2012
36. Green DM, Kun LE, Matthay KK, et al: Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors. Pediatr Blood Cancer 60:1083-1094, 2013